Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab After Thoracic Radiation in Advanced NSCLC
NCT04167657Phase 2Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2019
- Primary completion
- Nov 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in non-small cell lung cancer (NSCLC), sponsored by Peking Union Medical College Hospital. Started Apr 2019; status: completed.
02
Drugs
sintilimab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04167657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04167657.